Pfizer and BioNTech approved by DRAP

Islamabad: “We are pleased to announce that Pfizer and BioNTech have received an emergency use authorization from the The Drug Regulatory Authority of Pakistan (DRAP) to supply its COVID-19 vaccine in Pakistan’s immunization program. We commend the Government of Pakistan for its careful assessment of our COVID-19 vaccine and timely action to help protect the people of the country. This marks a historic moment further affirming Pfizer’s commitment to the people of Pakistan”. said S. M. Wajeeh, Country Manager Pfizer Pakistan. “We are proud of the fact that a COVAX shipment with Pfizer-BioNTech COVID-19 vaccines have arrived in the country.”